Literature DB >> 872451

Immunological studies of patients with asbestosis. I. Studies of cell-mediated immunity.

E Kagan, A Solomon, J C Cochrane, E I Beissner, J Gluckman, P H Rocks, I Webster.   

Abstract

A variety of cancers have been documented in patients exposed to asbestos dust. Since a deranged immune system may play a rôle in cancer development, the general level of immunocompetence was studied in a group of twenty-six patients with radiographically defined asbestosis, who might be at risk of developing asbestos-related neoplasms. Statistical comparisons were made with a comparable control group. A disproportionate number of the patients displayed cutaneous energy to certain recall antigens and to 2,4-dinitrochlorobenzene. In vitro studies of cellular immunity, as evaluated by phytohaemagglutinin-induced proliferative and cytotoxicity assays, showed significantly lower values amongst the patient group. Serum inhibitors of mitogen-induced lymphocyte transformation were also detected in several of the patients. The possible significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 872451      PMCID: PMC1540761     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.

Authors:  J C WAGNER; C A SLEGGS; P MARCHAND
Journal:  Br J Ind Med       Date:  1960-10

2.  Circulating rheumatoid factor and antinuclear antibodies in shipyard asbestos workers with pleural plaques.

Authors:  D Stansfield; J R Edge
Journal:  Br J Dis Chest       Date:  1974-07

3.  Asbestos and laryngeal carcinoma.

Authors:  P M Stell; T McGill
Journal:  Lancet       Date:  1973-08-25       Impact factor: 79.321

4.  Combined effect of asbestos exposure and smoking on mortality from lung cancer in factory workers.

Authors:  G Berry; M L Newhouse; M Turok
Journal:  Lancet       Date:  1972-09-02       Impact factor: 79.321

5.  Rapid preparation of lymphocytes for tissue-typing.

Authors:  R Harris; E O Ukaejiofo
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

6.  Phytohaemagglutinin-induced cytotoxic effector lymphocyte function in patients with the Wiskott-Aldrich syndrome (WAS).

Authors:  G Sherwood; R M Blaese
Journal:  Clin Exp Immunol       Date:  1973-04       Impact factor: 4.330

7.  Asbestos and malignancy.

Authors:  I Webster
Journal:  S Afr Med J       Date:  1973-02-03

8.  Asbestos-dust exposures at various levels and mortality.

Authors:  P E Enterline; M A Kendrick
Journal:  Arch Environ Health       Date:  1967-08

9.  Asbestosis and neoplastic disorders of the hematopoietic system.

Authors:  M A Gerber
Journal:  Am J Clin Pathol       Date:  1970-02       Impact factor: 2.493

10.  Malignancies in asbestos workers.

Authors:  J Lieben
Journal:  Arch Environ Health       Date:  1966-11
View more
  28 in total

1.  Asbestos-related lung disease.

Authors: 
Journal:  West J Med       Date:  1979-09

Review 2.  Diagnostic methods in occupational allergic lung disease.

Authors:  M Lopez; J E Salvaggio
Journal:  Clin Rev Allergy       Date:  1986-08

Review 3.  Immunotoxicology.

Authors:  K Miller
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

4.  High frequency of immune dysfunctions in asbestos workers and in patients with malignant mesothelioma.

Authors:  F Lew; P Tsang; J F Holland; N Warner; I J Selikoff; J G Bekesi
Journal:  J Clin Immunol       Date:  1986-05       Impact factor: 8.317

Review 5.  Pathogenesis of occupational lung disease.

Authors:  B F Paterson; R Patterson; L C Grammer
Journal:  Clin Rev Allergy       Date:  1986-08

Review 6.  Pleural mesothelioma associated with non-Hodgkin's lymphoma.

Authors:  M Tondini; G Rocco; M Travaglini; G Rossi; A Buscemi; L de Fazio
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

7.  Antibody producing cells in the spleens of mice treated with pathogenic mineral dust.

Authors:  S Szymaniec; D M Brown; M Chladzynska; E Jankowska; H Polikowska; K Donaldson
Journal:  Br J Ind Med       Date:  1989-10

8.  Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma.

Authors:  L S Manning; M R Davis; B W Robinson
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

9.  Reduced killer cell activity of lymphocytes from patients with asbestosis.

Authors:  M Kubota; S Kagamimori; K Yokoyama; A Okada
Journal:  Br J Ind Med       Date:  1985-04

10.  In vitro depression of human lymphocyte mitogen response (phytohaemagglutinin) by asbestos fibres.

Authors:  R G Barbers; W W Shih; A Saxon
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.